• USA
    • GER
    • CHI
    • FRA
    • PT(BR)
    • U.K.

Risk Reduction Solutions for
Pharmaceutical, Life Sciences & Healthcare

  • USA
    • GER
    • CHI
    • FRA
    • PT(BR)
    • U.K.
  • Resources
    • FAQs
    • Quality Certificates
    • Studies & Publications
    • Bioquell QuAD Data Portal
    • Material Safety Data Sheets
  • News & Events
  • Company
    • About Us
    • Company Locations
    • Distributors
    • Careers
    • Ecolab Life Sciences
  • Pharmaceuticals & Life Sciences
    • Our Technology for Life Sciences
    • Why Bioquell Technology?
    • Systems for Life Sciences
    • Rapid Bio Decontamination Service
    • Validation
    • Consumables & Related Accessories
    • Ecolab Life Sciences
  • Healthcare
    • Why Bioquell Technology?
    • The Bioquell Process
    • Bioquell Compared to UV
    • Vaporized vs Aerosolized
    • Systems for Healthcare
    • Services for Healthcare
    • Consumables & Related Accessories
  • EMS
  • Rapid Bio Decontamination Service
    • For Life Sciences
    • For Healthcare
    • Business Continuity
    • Applications
      • Remediation Needs
      • Emergency Response
      • Disaster Recovery Plan
      • Commissioning
      • End of Campaign and Facility Restart
      • Lab and Research Spaces
      • Hospital Related Contamination Events
  • Qube Isolator
    • About the Bioquell Qube
    • For Sterility Testing
  • Contact
notification

Bioquell and COVID-19
Learn more about Bioquell and Ecolabs response, our solutions, the latest news, and key information about the COVID-19 pandemic.

Click here for more information. 

x
    • Pharmaceuticals & Life Sciences
      • Our Technology for Life Sciences
      • Why Bioquell Technology?
      • Systems for Life Sciences
      • Rapid Bio Decontamination Service
      • Validation
      • Consumables & Related Accessories
      • Ecolab Life Sciences
    • Healthcare
      • Why Bioquell Technology?
      • The Bioquell Process
      • Bioquell Compared to UV
      • Vaporized vs Aerosolized
      • Systems for Healthcare
      • Services for Healthcare
      • Consumables & Related Accessories
    • EMS
    • Rapid Bio Decontamination Service
      • For Life Sciences
      • For Healthcare
      • Business Continuity
      • Applications
        • Remediation Needs
        • Emergency Response
        • Disaster Recovery Plan
        • Commissioning
        • End of Campaign and Facility Restart
        • Lab and Research Spaces
        • Hospital Related Contamination Events
    • Qube Isolator
      • About the Bioquell Qube
      • For Sterility Testing
    • Contact

News

Bioquell Qube to Polish manufacturing site

March 2017

The Polish subsidiary of a major international generics and specialty pharmaceutical manufacturer has chosen a Bioquell Qube M-11 system to provide the ideal environment for carrying out its product sterility testing. Previously, the quality department had been performing sterility testing utilising a laminar flow system and cleanroom for product protection.  The critical nature of such testing and the […]

Read More

US CDC updates recommendations on Candida auris

February 2017

Candida auris is an emerging pathogen with a high level of resistance to standard anti-fungal treatments. It is a causative agent of candidiasis, which when systemic (i.e. within the bloodstream) can result in high levels of mortality. The US CDC released guidance last year on the reporting, diagnosis, treatment and control of C.auris. On the 16th February, […]

Read More

Bioquell welcomes clarification of biocide regulations by HSE

October 2016

Leading Biodecontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant. The HSE Biocides e-Bulletin 22 September 2016 is entitled ‘Active Substance Approval Reminder’ and summarises all of the key dates for the evaluation of hydrogen peroxide in Product Types 1, 2, 3, 4, […]

Read More

Optimizing the Biodecontamination process to minimize production downtime

April 2016

A multi-national vaccine manufacturer approached Bioquell in order to perform a Biodecontamination within its FDA approved facility. The facility itself, some 5,500 cubic meters, was treated as a single Biodecontamination enclosure with the entire process completed within 30 hours. After a successful deployment of the project,the customer contacted Bioquell wishing to establish an industry leading […]

Read More

Leading bioprocessing institute to use new QUBE aseptic workstation

March 2016

The latest generation isolator was installed at the National Institute for Bioprocessing Research and Training (NIBRT) based in Dublin, Ireland, this February. The Bioquell QUBE, a flexible aseptic workstation, is now up and running to assist with continual professional development at this leading institute for the life sciences industry. From order to installation, it only […]

Read More

Tennessee Hospital Identifies Genetic Mutation in VRE

January 2016

A team from St Jude’s Hospital in Memphis, Tennessee have identified a genetic mutation within a VRE bacteria that appears to confer wide ranging antibiotic tolerance, particularly in a biofilm presentation. Published in January’s edition of mBIO (American Society for Microbiology) the research findings came about due to an extremely difficult case of bacteraemia in a 6 […]

Read More
Tags
All
authorization
BPR
hpv-aq
legal
<< 1 … 3 4 5

Sales and Technical Support & General Inquiries: +1 215 682 0225

702 Electronic Drive, Suite 200, Horsham, PA 19044

bioquellusorders@ecolab.com

  • © Bioquell, An Ecolab Solution 2025 All Rights Reserved
  • Privacy Policy
  • Terms of Use
Download PDF